Medline (MDLN) EPS (Basic) (2025 - 2026)

Medline (MDLN) reported EPS (Basic) of $0.16 for Q1 2026, up 730.96% year-over-year from $0.02 in Q1 2025, and up 1700.0% on a QoQ basis from -$0.01 in Q4 2025.

Medline (MDLN) has 2 years of EPS (Basic) data on file, last reported at $0.16 in Q1 2026.

  • Quarterly EPS (Basic) rose 730.96% year-over-year to $0.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.17 (changed N/A YoY) and the FY2025 annual result came in at -$0.01, changed N/A from the prior year.
  • EPS (Basic) grew to $0.16 in Q1 2026 per MDLN's latest filing, from -$0.01 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.16 in Q1 2026 and bottomed at -$0.01 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn 2.31
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn -0.13
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn 0.16
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn 2.74
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn 1.93
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn 0.07
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn 1.58
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn 0.67
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn -0.03
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn 1.13

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 0.16
Dec 31, 2025 -0.01
Mar 29, 2025 0.02